DBV Technologies (DBVT) Intangibles (2015 - 2026)
DBV Technologies (DBVT) posted Intangibles of $100000.0 for Q1 2026, up 376.19% sequentially from $21000.0 in Q3 2025, and up 244.83% YoY from $29000.0 in Q1 2025.
DBV Technologies (DBVT) Intangibles (2015 - 2026) Analysis & Trends
DBV Technologies has reported Intangibles for 12 years, with the latest figure at $100000.0 in Q1 2026.
- Quarterly Intangibles rose 244.83% year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100000.0 (up 244.83% YoY) and the FY2024 annual result came in at $40000.0, down 31.03% from the prior year.
- Intangibles rose to $100000.0 in Q1 2026 per DBVT's latest filing, from $21000.0 in the prior quarter.
- Over five years, Intangibles peaked at $100000.0 in Q1 2026 and troughed at $10000.0 in Q4 2022.
- A 5-year average of $37937.5 and a median of $34500.0 in 2024 frame the typical range for Intangibles.
- The sharpest annual moves came in 2022 and 2023: Intangibles sank 57.69% in 2022, then soared 480.0% in 2023.
- Over 5 years, Intangibles stood at $10000.0 in 2022, then jumped by 480.0% to $58000.0 in 2023, then sank by 31.03% to $40000.0 in 2024, then tumbled by 47.5% to $21000.0 in 2025, then soared by 376.19% to $100000.0 in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $100000.0, $21000.0, and $26000.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 266.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 63.28 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 60.96 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 93.49 Mn |
| 10 | DBV Technologies | 6.08 Bn | 5.90 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Sep 30, 2025 | 21,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | 29,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Sep 30, 2024 | 43,000.00 |
| Jun 30, 2024 | 46,000.00 |
| Mar 31, 2024 | 52,000.00 |
| Dec 31, 2023 | 58,000.00 |
| Sep 30, 2023 | 61,000.00 |
| Jun 30, 2023 | 68,000.00 |
| Mar 31, 2023 | 10,000.00 |
| Dec 31, 2022 | 10,000.00 |
| Sep 30, 2022 | 11,000.00 |
| Jun 30, 2022 | 14,000.00 |
| Mar 31, 2022 | 18,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | 26,000.00 |
| Jun 30, 2021 | 25,000.00 |
| Mar 31, 2021 | 32,000.00 |